AIDS Vaccine 04
International conference in Lausanne provided an update on recent scientific progress
Vol. 08, No. 3, Sep.-Nov. 2004
AIDS Vaccine 04, HIV Prevention, Bangkok 2004, Reports from the Frontlines, Forecasting the future, An Interview with Gary Nabel, Viral diversity, Vaccine science in Bangkok, Vaccine Briefs, Research Briefs
An Interview with Gary Nabel
Immunology and AIDS Vaccines
Bangkok 2004
A glimpse of the future at the dawn of the “scale-up” effort
Forecasting the future
Studies at Bangkok explore upcoming issues in trials, delivery and demand
HIV Prevention: Rethinking the Risk of Transmission
By Myron S. Cohen, MD*
Great hope has been pinned on biological solutions to HIV prevention including vaccines, topical microbicide agents, male circumcision, and novel use of antiretroviral therapy.
Reports from the Frontlines
AIDS vaccine trial site experiences from a busy year
Research Briefs
By Roberto Fernandez-Larsson, Ph.D.*
Topical CCR5 inhibitor prevents vaginal transmission of SHIV
Vaccine Briefs
By Roberto Fernandez-Larsson, Ph.D.*
Disappointing results from DNA/ MVA AIDS vaccine candidates
Vaccine science in Bangkok
By Richard Jefferys*
Over the past several years, there has been a sense that both the number and overall quality of the basic science presentations at the International AIDS Conference has declined.
Viral diversity, a growing feature of the HIV pandemic
By Sheri Fink, MD, PhD*
The International AIDS Conference in Bangkok added new layers of subtlety to the understanding of HIV genetic diversity and the pace of its evolution.